Structure

Physi-Chem Properties

Molecular Weight:  270.09
Volume:  282.249
LogP:  2.703
LogD:  2.799
LogS:  -3.328
# Rotatable Bonds:  4
TPSA:  66.76
# H-Bond Aceptor:  4
# H-Bond Donor:  2
# Rings:  2
# Heavy Atoms:  4

MedChem Properties

QED Drug-Likeness Score:  0.662
Synthetic Accessibility Score:  1.905
Fsp3:  0.062
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.731
MDCK Permeability:  1.3906368621974252e-05
Pgp-inhibitor:  0.006
Pgp-substrate:  0.021
Human Intestinal Absorption (HIA):  0.007
20% Bioavailability (F20%):  0.004
30% Bioavailability (F30%):  0.015

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.215
Plasma Protein Binding (PPB):  99.8729476928711%
Volume Distribution (VD):  0.51
Pgp-substrate:  0.7996830344200134%

ADMET: Metabolism

CYP1A2-inhibitor:  0.946
CYP1A2-substrate:  0.745
CYP2C19-inhibitor:  0.77
CYP2C19-substrate:  0.064
CYP2C9-inhibitor:  0.68
CYP2C9-substrate:  0.937
CYP2D6-inhibitor:  0.459
CYP2D6-substrate:  0.888
CYP3A4-inhibitor:  0.784
CYP3A4-substrate:  0.325

ADMET: Excretion

Clearance (CL):  11.616
Half-life (T1/2):  0.934

ADMET: Toxicity

hERG Blockers:  0.053
Human Hepatotoxicity (H-HT):  0.175
Drug-inuced Liver Injury (DILI):  0.525
AMES Toxicity:  0.538
Rat Oral Acute Toxicity:  0.692
Maximum Recommended Daily Dose:  0.508
Skin Sensitization:  0.936
Carcinogencity:  0.777
Eye Corrosion:  0.027
Eye Irritation:  0.967
Respiratory Toxicity:  0.856

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC66905

Natural Product ID:  NPC66905
Common Name*:   (E)-3-(4-Hydroxy-3-Methoxyphenyl)-1-(4-Hydroxyphenyl)Prop-2-En-1-One
IUPAC Name:   (E)-3-(4-hydroxy-3-methoxyphenyl)-1-(4-hydroxyphenyl)prop-2-en-1-one
Synonyms:  
Standard InCHIKey:  CHEDQLDLYXAMNI-KRXBUXKQSA-N
Standard InCHI:  InChI=1S/C16H14O4/c1-20-16-10-11(3-9-15(16)19)2-8-14(18)12-4-6-13(17)7-5-12/h2-10,17,19H,1H3/b8-2+
SMILES:  COc1cc(/C=C/C(=O)c2ccc(cc2)O)ccc1O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2263299
PubChem CID:   10659647
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0003467] Linear 1,3-diarylpropanoids
        • [CHEMONTID:0001630] Chalcones and dihydrochalcones
          • [CHEMONTID:0003474] Retrochalcones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO26741 Anemarrhena asphodeloides Species Asparagaceae Eukaryota rhizomes n.a. n.a. PMID[19757853]
NPO26741 Anemarrhena asphodeloides Species Asparagaceae Eukaryota n.a. rhizome n.a. PMID[21370894]
NPO26741 Anemarrhena asphodeloides Species Asparagaceae Eukaryota Rhizomes n.a. n.a. PMID[8482946]
NPO26741 Anemarrhena asphodeloides Species Asparagaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO26741 Anemarrhena asphodeloides Species Asparagaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO28394 Rohdea chinensis Species Asparagaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO26741 Anemarrhena asphodeloides Species Asparagaceae Eukaryota n.a. n.a. n.a. Database[TCM_Taiwan]
NPO26741 Anemarrhena asphodeloides Species Asparagaceae Eukaryota n.a. n.a. n.a. Database[TM-MC]
NPO28394 Rohdea chinensis Species Asparagaceae Eukaryota n.a. n.a. n.a. Database[UNPD]
NPO26741 Anemarrhena asphodeloides Species Asparagaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT32 Organism Mus musculus Mus musculus Inhibition = 7.83 % PMID[478966]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC66905 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.944 High Similarity NPC5018
0.944 High Similarity NPC123228
0.944 High Similarity NPC276466
0.944 High Similarity NPC32163
0.944 High Similarity NPC151167
0.944 High Similarity NPC123722
0.944 High Similarity NPC16651
0.936 High Similarity NPC179777
0.936 High Similarity NPC303680
0.936 High Similarity NPC84076
0.936 High Similarity NPC90128
0.9291 High Similarity NPC304622
0.9231 High Similarity NPC144662
0.9225 High Similarity NPC50763
0.9206 High Similarity NPC276014
0.9179 High Similarity NPC110419
0.9134 High Similarity NPC203719
0.9134 High Similarity NPC117237
0.9127 High Similarity NPC53305
0.9127 High Similarity NPC257589
0.912 High Similarity NPC229084
0.912 High Similarity NPC164778
0.912 High Similarity NPC18984
0.912 High Similarity NPC257976
0.912 High Similarity NPC4181
0.912 High Similarity NPC106659
0.912 High Similarity NPC242372
0.912 High Similarity NPC160900
0.9111 High Similarity NPC229218
0.9111 High Similarity NPC176030
0.9111 High Similarity NPC192597
0.9111 High Similarity NPC141817
0.9111 High Similarity NPC169214
0.9111 High Similarity NPC312256
0.9098 High Similarity NPC284409
0.9055 High Similarity NPC92207
0.9055 High Similarity NPC127937
0.9048 High Similarity NPC312404
0.9048 High Similarity NPC273686
0.9044 High Similarity NPC46161
0.9044 High Similarity NPC254659
0.9044 High Similarity NPC239608
0.9044 High Similarity NPC46880
0.904 High Similarity NPC114298
0.9032 High Similarity NPC109083
0.9032 High Similarity NPC189844
0.9032 High Similarity NPC60962
0.9032 High Similarity NPC224814
0.9032 High Similarity NPC269843
0.9032 High Similarity NPC14007
0.9032 High Similarity NPC158949
0.9015 High Similarity NPC139519
0.8978 High Similarity NPC207732
0.8978 High Similarity NPC142165
0.8963 High Similarity NPC326065
0.8963 High Similarity NPC28398
0.8947 High Similarity NPC324929
0.8931 High Similarity NPC111888
0.8923 High Similarity NPC298268
0.8923 High Similarity NPC172673
0.8915 High Similarity NPC226661
0.8913 High Similarity NPC157133
0.8905 High Similarity NPC50954
0.8889 High Similarity NPC474784
0.8889 High Similarity NPC286573
0.888 High Similarity NPC225245
0.8872 High Similarity NPC204592
0.8872 High Similarity NPC208760
0.8871 High Similarity NPC299406
0.8864 High Similarity NPC283823
0.8864 High Similarity NPC159418
0.8849 High Similarity NPC153644
0.8849 High Similarity NPC165389
0.8832 High Similarity NPC284556
0.8832 High Similarity NPC301178
0.8819 High Similarity NPC163083
0.8815 High Similarity NPC325625
0.881 High Similarity NPC201777
0.8788 High Similarity NPC239302
0.8779 High Similarity NPC123196
0.8779 High Similarity NPC215941
0.8779 High Similarity NPC319282
0.8779 High Similarity NPC275724
0.8779 High Similarity NPC137427
0.8779 High Similarity NPC65935
0.8779 High Similarity NPC311419
0.8779 High Similarity NPC244246
0.8777 High Similarity NPC160777
0.8777 High Similarity NPC287495
0.8777 High Similarity NPC73416
0.8777 High Similarity NPC9370
0.8768 High Similarity NPC471417
0.8768 High Similarity NPC119663
0.8759 High Similarity NPC84273
0.875 High Similarity NPC30216
0.8723 High Similarity NPC203747
0.8723 High Similarity NPC474903
0.8723 High Similarity NPC194653
0.8723 High Similarity NPC80710
0.8723 High Similarity NPC254702
0.8723 High Similarity NPC139364
0.8722 High Similarity NPC327410
0.871 High Similarity NPC280001
0.8705 High Similarity NPC105213
0.8705 High Similarity NPC275278
0.8692 High Similarity NPC281020
0.8682 High Similarity NPC3221
0.8672 High Similarity NPC474691
0.8667 High Similarity NPC90431
0.8662 High Similarity NPC92722
0.8662 High Similarity NPC69430
0.8662 High Similarity NPC40290
0.8662 High Similarity NPC264550
0.8662 High Similarity NPC333691
0.8662 High Similarity NPC139293
0.8662 High Similarity NPC195763
0.8662 High Similarity NPC200060
0.8662 High Similarity NPC102003
0.8662 High Similarity NPC142876
0.8662 High Similarity NPC264289
0.8661 High Similarity NPC177291
0.8661 High Similarity NPC194416
0.8657 High Similarity NPC237330
0.8652 High Similarity NPC58373
0.8652 High Similarity NPC472969
0.8636 High Similarity NPC285776
0.8633 High Similarity NPC287722
0.8633 High Similarity NPC473090
0.8615 High Similarity NPC213552
0.8615 High Similarity NPC120225
0.8613 High Similarity NPC4796
0.8605 High Similarity NPC246704
0.8601 High Similarity NPC472279
0.8601 High Similarity NPC58310
0.8601 High Similarity NPC295977
0.8593 High Similarity NPC89504
0.8593 High Similarity NPC95485
0.8593 High Similarity NPC274613
0.8593 High Similarity NPC88065
0.8592 High Similarity NPC15329
0.8592 High Similarity NPC98809
0.8592 High Similarity NPC476394
0.8592 High Similarity NPC287395
0.8592 High Similarity NPC183655
0.8592 High Similarity NPC131451
0.8583 High Similarity NPC295317
0.8582 High Similarity NPC12377
0.8571 High Similarity NPC300603
0.8571 High Similarity NPC91694
0.8561 High Similarity NPC241354
0.856 High Similarity NPC185738
0.856 High Similarity NPC150919
0.8551 High Similarity NPC908
0.8551 High Similarity NPC138438
0.8551 High Similarity NPC50823
0.855 High Similarity NPC293641
0.855 High Similarity NPC20404
0.855 High Similarity NPC12022
0.855 High Similarity NPC20287
0.8542 High Similarity NPC473201
0.8542 High Similarity NPC78505
0.8542 High Similarity NPC302783
0.8542 High Similarity NPC144283
0.8542 High Similarity NPC306011
0.8542 High Similarity NPC256406
0.8542 High Similarity NPC118427
0.8542 High Similarity NPC31363
0.8542 High Similarity NPC472838
0.8538 High Similarity NPC280767
0.8538 High Similarity NPC289459
0.8531 High Similarity NPC287101
0.8531 High Similarity NPC223579
0.8531 High Similarity NPC183950
0.8531 High Similarity NPC237441
0.8531 High Similarity NPC52005
0.8531 High Similarity NPC137062
0.8521 High Similarity NPC93034
0.8521 High Similarity NPC119660
0.8521 High Similarity NPC188074
0.8521 High Similarity NPC125449
0.8519 High Similarity NPC471110
0.8507 High Similarity NPC153453
0.85 High Similarity NPC469615
0.8492 Intermediate Similarity NPC272471
0.8492 Intermediate Similarity NPC107588
0.8492 Intermediate Similarity NPC137537
0.8492 Intermediate Similarity NPC164706
0.8492 Intermediate Similarity NPC470626
0.8492 Intermediate Similarity NPC70744
0.8489 Intermediate Similarity NPC472410
0.8485 Intermediate Similarity NPC110313
0.8485 Intermediate Similarity NPC278308
0.8483 Intermediate Similarity NPC121522
0.8483 Intermediate Similarity NPC39732
0.8483 Intermediate Similarity NPC245382
0.8483 Intermediate Similarity NPC477231
0.8483 Intermediate Similarity NPC209487
0.8483 Intermediate Similarity NPC291802
0.8483 Intermediate Similarity NPC131266
0.8483 Intermediate Similarity NPC181209

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC66905 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9134 High Similarity NPD9494 Approved
0.912 High Similarity NPD4379 Clinical (unspecified phase)
0.856 High Similarity NPD5536 Phase 2
0.8356 Intermediate Similarity NPD1934 Approved
0.8311 Intermediate Similarity NPD3882 Suspended
0.8299 Intermediate Similarity NPD2801 Approved
0.8226 Intermediate Similarity NPD228 Approved
0.8182 Intermediate Similarity NPD1511 Approved
0.8069 Intermediate Similarity NPD1512 Approved
0.8056 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.8054 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.803 Intermediate Similarity NPD3972 Approved
0.7972 Intermediate Similarity NPD4628 Phase 3
0.7971 Intermediate Similarity NPD1240 Approved
0.7971 Intermediate Similarity NPD943 Approved
0.7943 Intermediate Similarity NPD2935 Discontinued
0.7914 Intermediate Similarity NPD230 Phase 1
0.7891 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7872 Intermediate Similarity NPD1510 Phase 2
0.7857 Intermediate Similarity NPD1607 Approved
0.7829 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7821 Intermediate Similarity NPD6166 Phase 2
0.7821 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7821 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7812 Intermediate Similarity NPD5283 Phase 1
0.7786 Intermediate Similarity NPD447 Suspended
0.7785 Intermediate Similarity NPD824 Approved
0.7778 Intermediate Similarity NPD1876 Approved
0.7763 Intermediate Similarity NPD3817 Phase 2
0.7762 Intermediate Similarity NPD2344 Approved
0.7754 Intermediate Similarity NPD3027 Phase 3
0.7722 Intermediate Similarity NPD3818 Discontinued
0.7674 Intermediate Similarity NPD1241 Discontinued
0.7673 Intermediate Similarity NPD7054 Approved
0.7671 Intermediate Similarity NPD2354 Approved
0.7667 Intermediate Similarity NPD3455 Phase 2
0.7655 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7652 Intermediate Similarity NPD9545 Approved
0.7625 Intermediate Similarity NPD7472 Approved
0.7625 Intermediate Similarity NPD7074 Phase 3
0.7616 Intermediate Similarity NPD4380 Phase 2
0.7586 Intermediate Similarity NPD1549 Phase 2
0.7582 Intermediate Similarity NPD1465 Phase 2
0.758 Intermediate Similarity NPD6232 Discontinued
0.7568 Intermediate Similarity NPD6799 Approved
0.7566 Intermediate Similarity NPD6386 Approved
0.7566 Intermediate Similarity NPD6385 Approved
0.7551 Intermediate Similarity NPD6190 Approved
0.7551 Intermediate Similarity NPD2309 Approved
0.755 Intermediate Similarity NPD7458 Discontinued
0.7547 Intermediate Similarity NPD7473 Discontinued
0.7536 Intermediate Similarity NPD2798 Approved
0.7535 Intermediate Similarity NPD1933 Approved
0.7518 Intermediate Similarity NPD1283 Approved
0.7517 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.7517 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7517 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD3021 Approved
0.75 Intermediate Similarity NPD1608 Approved
0.75 Intermediate Similarity NPD2799 Discontinued
0.75 Intermediate Similarity NPD9269 Phase 2
0.75 Intermediate Similarity NPD3022 Approved
0.7483 Intermediate Similarity NPD8166 Discontinued
0.7469 Intermediate Similarity NPD6797 Phase 2
0.7466 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7464 Intermediate Similarity NPD1203 Approved
0.7463 Intermediate Similarity NPD1651 Approved
0.7436 Intermediate Similarity NPD7075 Discontinued
0.7423 Intermediate Similarity NPD7685 Pre-registration
0.7423 Intermediate Similarity NPD7251 Discontinued
0.7419 Intermediate Similarity NPD5978 Approved
0.7419 Intermediate Similarity NPD5977 Approved
0.7397 Intermediate Similarity NPD2353 Approved
0.7397 Intermediate Similarity NPD2355 Clinical (unspecified phase)
0.7379 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7378 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7378 Intermediate Similarity NPD7808 Phase 3
0.7372 Intermediate Similarity NPD1481 Phase 2
0.7365 Intermediate Similarity NPD3750 Approved
0.7365 Intermediate Similarity NPD4110 Phase 3
0.7365 Intermediate Similarity NPD4109 Clinical (unspecified phase)
0.7362 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7355 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7346 Intermediate Similarity NPD5844 Phase 1
0.7342 Intermediate Similarity NPD5494 Approved
0.7338 Intermediate Similarity NPD6873 Phase 2
0.7333 Intermediate Similarity NPD4357 Discontinued
0.7329 Intermediate Similarity NPD2796 Approved
0.7325 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7324 Intermediate Similarity NPD6798 Discontinued
0.7324 Intermediate Similarity NPD2313 Discontinued
0.7324 Intermediate Similarity NPD3764 Approved
0.7315 Intermediate Similarity NPD3887 Approved
0.7305 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7299 Intermediate Similarity NPD1535 Discovery
0.7299 Intermediate Similarity NPD1281 Approved
0.7299 Intermediate Similarity NPD1547 Clinical (unspecified phase)
0.7296 Intermediate Similarity NPD2821 Approved
0.7292 Intermediate Similarity NPD6355 Discontinued
0.7285 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7279 Intermediate Similarity NPD2346 Discontinued
0.7279 Intermediate Similarity NPD17 Approved
0.7273 Intermediate Similarity NPD7028 Phase 2
0.7273 Intermediate Similarity NPD4062 Phase 3
0.7273 Intermediate Similarity NPD6233 Phase 2
0.7273 Intermediate Similarity NPD6599 Discontinued
0.726 Intermediate Similarity NPD4308 Phase 3
0.7259 Intermediate Similarity NPD1894 Discontinued
0.7254 Intermediate Similarity NPD7095 Approved
0.7248 Intermediate Similarity NPD7003 Approved
0.7246 Intermediate Similarity NPD9717 Approved
0.7246 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7244 Intermediate Similarity NPD1006 Clinical (unspecified phase)
0.7244 Intermediate Similarity NPD7819 Suspended
0.7239 Intermediate Similarity NPD9493 Approved
0.7234 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7226 Intermediate Similarity NPD3847 Discontinued
0.7222 Intermediate Similarity NPD1613 Approved
0.7222 Intermediate Similarity NPD3620 Phase 2
0.7222 Intermediate Similarity NPD4060 Phase 1
0.7222 Intermediate Similarity NPD3142 Approved
0.7222 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD1558 Phase 1
0.7222 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD3140 Approved
0.7219 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7209 Intermediate Similarity NPD9265 Clinical (unspecified phase)
0.7209 Intermediate Similarity NPD1358 Approved
0.7206 Intermediate Similarity NPD1357 Approved
0.7206 Intermediate Similarity NPD9268 Approved
0.7205 Intermediate Similarity NPD3926 Phase 2
0.7203 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7203 Intermediate Similarity NPD3268 Approved
0.7194 Intermediate Similarity NPD2983 Phase 2
0.7194 Intermediate Similarity NPD2982 Phase 2
0.719 Intermediate Similarity NPD6662 Clinical (unspecified phase)
0.7183 Intermediate Similarity NPD6832 Phase 2
0.7179 Intermediate Similarity NPD6801 Discontinued
0.7172 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.717 Intermediate Similarity NPD919 Approved
0.7162 Intermediate Similarity NPD7266 Discontinued
0.7154 Intermediate Similarity NPD9296 Approved
0.7153 Intermediate Similarity NPD2674 Phase 3
0.7133 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7126 Intermediate Similarity NPD3534 Clinical (unspecified phase)
0.7124 Intermediate Similarity NPD6273 Approved
0.7124 Intermediate Similarity NPD5049 Phase 3
0.7122 Intermediate Similarity NPD2981 Phase 2
0.7118 Intermediate Similarity NPD6377 Clinical (unspecified phase)
0.7115 Intermediate Similarity NPD7411 Suspended
0.7111 Intermediate Similarity NPD405 Clinical (unspecified phase)
0.7099 Intermediate Similarity NPD5242 Approved
0.7097 Intermediate Similarity NPD3226 Approved
0.7095 Intermediate Similarity NPD1551 Phase 2
0.7092 Intermediate Similarity NPD2797 Approved
0.7092 Intermediate Similarity NPD1470 Approved
0.7089 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7083 Intermediate Similarity NPD411 Approved
0.7083 Intermediate Similarity NPD3144 Approved
0.7083 Intermediate Similarity NPD3145 Approved
0.7081 Intermediate Similarity NPD1247 Approved
0.708 Intermediate Similarity NPD4196 Clinical (unspecified phase)
0.7071 Intermediate Similarity NPD3600 Clinical (unspecified phase)
0.7063 Intermediate Similarity NPD6234 Discontinued
0.705 Intermediate Similarity NPD1201 Approved
0.7047 Intermediate Similarity NPD1471 Phase 3
0.7047 Intermediate Similarity NPD2343 Clinical (unspecified phase)
0.7039 Intermediate Similarity NPD7440 Discontinued
0.7029 Intermediate Similarity NPD4626 Approved
0.7027 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7027 Intermediate Similarity NPD3748 Approved
0.7023 Intermediate Similarity NPD2684 Approved
0.7006 Intermediate Similarity NPD7039 Approved
0.7006 Intermediate Similarity NPD7038 Approved
0.7006 Intermediate Similarity NPD7110 Phase 1
0.7006 Intermediate Similarity NPD7109 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD3134 Approved
0.6993 Remote Similarity NPD3018 Phase 2
0.6987 Remote Similarity NPD2649 Approved
0.6987 Remote Similarity NPD2651 Approved
0.6986 Remote Similarity NPD4307 Phase 2
0.6986 Remote Similarity NPD2979 Phase 3
0.6981 Remote Similarity NPD5353 Approved
0.6981 Remote Similarity NPD2296 Approved
0.6981 Remote Similarity NPD5402 Approved
0.698 Remote Similarity NPD2438 Suspended
0.6975 Remote Similarity NPD7199 Phase 2
0.6972 Remote Similarity NPD3266 Approved
0.6972 Remote Similarity NPD3267 Approved
0.697 Remote Similarity NPD2163 Approved
0.6968 Remote Similarity NPD5403 Approved
0.6962 Remote Similarity NPD37 Approved
0.6962 Remote Similarity NPD7577 Discontinued
0.6954 Remote Similarity NPD3060 Approved
0.6948 Remote Similarity NPD5401 Approved
0.6948 Remote Similarity NPD3146 Approved
0.6948 Remote Similarity NPD3688 Clinical (unspecified phase)
0.6948 Remote Similarity NPD4662 Approved
0.6948 Remote Similarity NPD7422 Clinical (unspecified phase)
0.6948 Remote Similarity NPD4661 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data